374 related articles for article (PubMed ID: 34291130)
1. Breast and gut microbiome in health and cancer.
Zhang J; Xia Y; Sun J
Genes Dis; 2021 Sep; 8(5):581-589. PubMed ID: 34291130
[TBL] [Abstract][Full Text] [Related]
2. Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis.
Zhang YG; Xia Y; Zhang J; Deb S; Garrett S; Sun J
Gut Microbes; 2023; 15(1):2202593. PubMed ID: 37074210
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
4. tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors.
Zhang J; Lu R; Zhang Y; Matuszek Ż; Zhang W; Xia Y; Pan T; Sun J
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32182756
[TBL] [Abstract][Full Text] [Related]
5. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
6. The Implication of the Gut Microbiome in Heart Failure.
Lupu VV; Adam Raileanu A; Mihai CM; Morariu ID; Lupu A; Starcea IM; Frasinariu OE; Mocanu A; Dragan F; Fotea S
Cells; 2023 Apr; 12(8):. PubMed ID: 37190067
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection.
Wang C; Li Q; Ren J
Front Immunol; 2019; 10():1873. PubMed ID: 31456801
[TBL] [Abstract][Full Text] [Related]
8. Hypertension promotes microbial translocation and dysbiotic shifts in the fecal microbiome of nonhuman primates.
Vemuri R; Ruggiero A; Whitfield JM; Dugan GO; Cline JM; Block MR; Guo H; Kavanagh K
Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H474-H485. PubMed ID: 35148233
[TBL] [Abstract][Full Text] [Related]
9. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
10. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
Tie Y; Huang Y; Chen R; Li L; Chen M; Zhang S
Gut Microbes; 2023 Dec; 15(2):2265028. PubMed ID: 37822139
[TBL] [Abstract][Full Text] [Related]
11. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases.
Mahmud MR; Akter S; Tamanna SK; Mazumder L; Esti IZ; Banerjee S; Akter S; Hasan MR; Acharjee M; Hossain MS; Pirttilä AM
Gut Microbes; 2022; 14(1):2096995. PubMed ID: 35866234
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis of skin microbiome and gut microbiome in melanoma progression.
Mekadim C; Skalnikova HK; Cizkova J; Cizkova V; Palanova A; Horak V; Mrazek J
BMC Microbiol; 2022 Feb; 22(1):63. PubMed ID: 35216552
[TBL] [Abstract][Full Text] [Related]
13. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
14. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
15. Human gut microbiota/microbiome in health and diseases: a review.
Gomaa EZ
Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
[TBL] [Abstract][Full Text] [Related]
16. Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment.
Ruo SW; Alkayyali T; Win M; Tara A; Joseph C; Kannan A; Srivastava K; Ochuba O; Sandhu JK; Went TR; Sultan W; Kantamaneni K; Poudel S
Cureus; 2021 Aug; 13(8):e17472. PubMed ID: 34513524
[TBL] [Abstract][Full Text] [Related]
17. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases.
Yang X; Lu D; Zhuo J; Lin Z; Yang M; Xu X
Int J Biol Sci; 2020; 16(13):2357-2366. PubMed ID: 32760203
[TBL] [Abstract][Full Text] [Related]
18. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
19. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
20. The human microbiome in disease and pathology.
Manos J
APMIS; 2022 Dec; 130(12):690-705. PubMed ID: 35393656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
